Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALIUS LIMITED Capital/Financing Update 2017

Sep 5, 2017

65058_rns_2017-09-05_1302423b-14d1-4453-b65f-748f51281940.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

ASX Announcement (ASX: PRY)

ASX Limited Market Announcements Office Exchange Centre Level 4, 20 Bridge Street SYDNEY NSW 2000

==> picture [138 x 40] intentionally omitted <==

ACN 064 530 516 REGISTERED OFFICE: LEVEL 6, 203 PACIFIC HIGHWAY ST LEONARDS NSW 2065 TEL: +61 2 9432 9400 FAX: +61 2 9432 9447

6 September 2017

Primary Health Care Limited (ASX: PRY) ‐ ASX Listing Rule 3.10.3 announcement Proposed Issue of Securities ‐ Employee Service Rights & Performance Rights

For the purposes of ASX Listing Rule 3.10.3, Primary Health Care Limited (ASX: PRY) provides the following information in relation to the proposed issue of securities.

Information required under Listing Rule
3.10.3
Information provided by PRY
Class of securities to be issued Indeterminate Rights (the Right on exercise to an
ordinary PRY Share, or equivalent cash value).
Number of securities to be issued 130,130(“A”)
134,521
(“B”)
2,858,400 (“C”)
3,123,051
TOTAL
Principal terms of securities to be issued Rights in “A”
The Rights in “A” above are subject to a 12 month
service test from 30 June 2017. The Shares resulting
from exercise of the Rights in “A” above, if any, are
expected to be issued around September 2018.
Rights in “B”
The Rights in “B” above are subject to a 24 month
service test from 30 June 2017. The Shares resulting
from exercise of the Rights in “B” above, if any, are
expected to be issued around September 2019.
Rights in “C”
The Rights in “C” above are subject to:
(a) a 36 month service test from 1 July 2016; and
(b) satisfaction of applicable performance
conditions over the period 1 July 2016 ‐ 30
June 2019 inclusive.
The Shares resulting from exercise of the Rights in “B”
above, if any, are expected to be issued around
September 2019.

1

Information required under Listing Rule
3.10.3
Information provided by PRY
Rights in “A”, Rights in “B” and Rights in “C”
The Shares that result from the exercise of the Rights,
if any, will rank equally with existing ordinary shares in
PRY.
The Rights carry no dividend or voting rights.
Issue price or consideration Nil.
Purpose of the issue Rights in “A” and Rights in “B”
The Rights in “A” and “B” form part of the
remuneration packages of management, being the
deferred equity portion of the Short‐term Incentive
(STI) awards made in relation to FY 2017.
Rights in “C”
The Rights in “C” form part of the remuneration
packages of management, being the deferred equity
portion of the Long‐term Incentive (LTI) awards made
in relation to FY 2017.
Whether the entity will seek security holder
approval in relation to the proposed issue
Security holder approval is not required for the issue
of the Rights.
Whether the issue will be to a class of
security holders
No.

PRY will lodge the relevant Appendix 3B when the new securities are issued.

==> picture [147 x 49] intentionally omitted <==

Charles Tilley Group Company Secretary

2